BSECompany Update19h ago · 2 Oct 2026, 06:35 pm
Intimation of completion of acquisition.
Aurobindo Pharma Ltd · 524804
✦ AI SummaryM&A
Aurobindo Pharma Ltd has completed the acquisition of the Contract Research Services business of A1 Biochem Group through its wholly-owned subsidiary Apitoria Pharma Private Limited.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Attachments (1)
📄pdf
Download →
9ff92478-1c8a-4967-bbe6-fdeaaa463fad.pdf
View document text
Date: October 2, 2026
To To
Listing Department, The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED
Exchange Plaza, Phiroz Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street,
MUMBAI - 400 051 MUMBAI - 400 001
Symbol: AUROPHARMA Scrip Code: 524804
Dear Sir/Madam,
Re: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements)
Regulations, 2015.
Ref: Our letters dated July 23, 2026, September 12, 2026, October 01, 2026, and October 02, 2026.
We refer to our letters dated July 23, 2026 and September 12, 2026, October 01, 2026, and October 02, 2026
informing that Apitoria Pharma Private Limited ("Apitoria"), a wholly owned subsidiary of the Company, is
acquiring the Contract Research Services business of A1 Biochem Group.
In continuation to the above and in compliance with Regulation 30 and other applicable provisions of the SEBI
LODR Regulations, this is to inform that post the completion of the conditions prescribed under the definitive
agreements, the acquisition of the business of A1 Biochem Group has been completed.
Apitoria now holds 80% ownership in A1 Biochem Labs (India) Private Limited (“A1 Labs India”) and 20%
ownership is held by Dr. Rajendra Gadikota (former promoter of A1 Biochem Group). Further, A1 Labs India,
through its wholly owned subsidiary A1 Biochem USA Inc, USA, has acquired 100% membership interest of A1
Biochem Labs LLC, USA (step-down subsidiary of A1 Labs India) which is operating in USA.
Through this acquisition, Apitoria now has access to an existing CRO platform with 50+ client base and
experience of completing 800+ projects in India and USA. This acquisition complements Apitoria’s
manufacturing capabilities to create an integrated CRDMO platform and expand the portfolio of offerings to
the customers and longer life cycle engagement with the customers.
This is for your information and record.
Thanking you,
Yours faithfully,
For AUROBINDO PHARMA LIMITED
B. Adi Reddy
Company Secretary
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833
Email: info@aurobindo.com Website: www.aurobindo.com